Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions
- PMID: 35233742
- PMCID: PMC11910204
- DOI: 10.1245/s10434-022-11443-1
Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions
Erratum in
-
Correction to: Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions.Ann Surg Oncol. 2022 Mar 17. doi: 10.1245/s10434-022-11652-8. Online ahead of print. Ann Surg Oncol. 2022. PMID: 35298763 No abstract available.
Abstract
Background: Nonpalpable breast lesions require precise preoperative localization to facilitate negative margins with breast-conserving therapy. The traditional use of wires has several challenges including patient discomfort, wire migration, and coordination of schedules between radiology and the operating room. Radioactive seed localization overcomes some of these challenges, but radiation safety requirements have limited adoption of this technology. The authors examined their institutional experience with Magseed as an alternative technology for localization and compared outcomes with those of wire and radioactive seed localization.
Methods: An institutional review board (IRB)-approved retrospective study was performed to evaluate patients who underwent excisional biopsy or segmental mastectomy after wire-guided localization (WGL), radioactive seed localization (RSL), or Magseed localization (ML). The clinical and pathologic factors of the three groups were assessed with a negative margin rate as the primary outcome measure.
Results: Of the 1835 patients in the study, 825 underwent WGL, 449 underwent RSL, and 561 underwent ML. For the patients with either multiple lesions or a large lesion that required bracketing, multiple localization devices were placed in 31% of the WGL patients, 28% of the RSL patients, and 23% of the ML patients (p = 0.006). Negative margins were achieved in 91% of the WGL patients, 89% of the RSL patients, and 89% of the ML patients (p = 0.4).
Conclusion: Localization of non-palpable breast lesions using Magseed is a safe and effective alternative to WGL and RSL that overcomes radiation safety limitations and increases radiology and surgery scheduling efficiency.
© 2022. Society of Surgical Oncology.
Figures
Similar articles
-
Radioactive Seed Localization Versus Wire-Guided Localization for Nonpalpable Breast Cancer: A Cost and Operating Room Efficiency Analysis.Ann Surg Oncol. 2017 Nov;24(12):3567-3573. doi: 10.1245/s10434-017-6084-z. Epub 2017 Sep 14. Ann Surg Oncol. 2017. PMID: 28913761
-
Adequacy of invasive and in situ breast carcinoma margins in radioactive seed and wire-guided localization lumpectomies.Breast J. 2021 Feb;27(2):134-140. doi: 10.1111/tbj.14115. Epub 2020 Dec 3. Breast J. 2021. PMID: 33270329
-
Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial.Ann Surg. 2017 Jul;266(1):29-35. doi: 10.1097/SLA.0000000000002101. Ann Surg. 2017. PMID: 28257326 Clinical Trial.
-
Comparison of Wire and Non-Wire Localisation Techniques in Breast Cancer Surgery: A Review of the Literature with Pooled Analysis.Medicina (Kaunas). 2023 Jul 13;59(7):1297. doi: 10.3390/medicina59071297. Medicina (Kaunas). 2023. PMID: 37512107 Free PMC article. Review.
-
Radioguided Surgery for Localization of Nonpalpable Breast Lesions A Mini-Review.Curr Radiopharm. 2016;9(2):114-20. doi: 10.2174/1874471009999160625105340. Curr Radiopharm. 2016. PMID: 27593254 Review.
Cited by
-
Reliability of Magseed® marking before neoadjuvant systemic therapy with subsequent contrast-enhanced mammography in patients with non-palpable breast cancer lesions after treatment: the MAGMA study.Breast Cancer Res Treat. 2024 Nov;208(1):133-143. doi: 10.1007/s10549-024-07407-6. Epub 2024 Jun 20. Breast Cancer Res Treat. 2024. PMID: 38898360 Free PMC article.
-
Breast-Conserving Surgery Guided with Magnetic Seeds vs. Wires: A Single-Institution Experience.Cancers (Basel). 2024 Jan 29;16(3):566. doi: 10.3390/cancers16030566. Cancers (Basel). 2024. PMID: 38339317 Free PMC article.
-
Wire-Free, Nonradioactive Localization Techniques to Guide Surgical Excision of Nonpalpable Breast Tumours: A Health Technology Assessment.Ont Health Technol Assess Ser. 2023 May 17;23(2):1-139. eCollection 2023. Ont Health Technol Assess Ser. 2023. PMID: 37284228 Free PMC article.
-
Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety.Breast Cancer Res Treat. 2023 Aug;201(1):67-75. doi: 10.1007/s10549-023-07006-x. Epub 2023 Jun 15. Breast Cancer Res Treat. 2023. PMID: 37322358 Free PMC article.
-
Evaluation of a Surgical Navigation System for Localization and Excision of Nonpalpable Lesions in Breast and Axillary Surgery.Breast J. 2023 Dec 23;2023:9993852. doi: 10.1155/2023/9993852. eCollection 2023. Breast J. 2023. PMID: 38162957 Free PMC article.
References
-
- Hall FM, Frank HA. Preoperative localization of nonpalpable breast lesions. AJR Am J Roentgenol. Jan 1979;132(1):101–105. - PubMed
-
- Hayes MK. Update on Preoperative Breast Localization. Radiol Clin North Am. May 2017;55(3):591–603. - PubMed
-
- Jeffries DO, Dossett LA, Jorns JM. Localization for Breast Surgery: The Next Generation. Arch Pathol Lab Med. Oct 2017;141(10):1324–1329. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical